Alpha Cognition (Alpha Cognition) Interest Expense : $-0.06 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Alpha Cognition Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Alpha Cognition's interest expense for the three months ended in Mar. 2024 was $ -0.02 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.06 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Alpha Cognition's Operating Income for the three months ended in Mar. 2024 was $ -4.32 Mil. Alpha Cognition's Interest Expense for the three months ended in Mar. 2024 was $ -0.02 Mil. Alpha Cognition did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Alpha Cognition Interest Expense Historical Data

The historical data trend for Alpha Cognition's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alpha Cognition Interest Expense Chart

Alpha Cognition Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Interest Expense

-0.77

-0.53

-0.17

-0.07

Alpha Cognition Quarterly Data
	Jan20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial										-0.03	-0.04	-0.04	0.04	-0.02

Alpha Cognition Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.06 Mil.

Alpha Cognition (OTCPK:ACOGF) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Alpha Cognition's Interest Expense for the three months ended in Mar. 2024 was $-0.02 Mil. Its Operating Income for the three months ended in Mar. 2024 was $-4.32 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was $0.00 Mil.

Alpha Cognition's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Alpha Cognition did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Alpha Cognition (Alpha Cognition) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alpha Cognition Inc (OTCPK:ACOGF) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

ACOG:Canada

Address

301 - 1228 Hamilton Street, Vancouver, BC, CAN, V6B 6L2

Website

https://www.alphacognition.com

Alpha Cognition Inc is a clinical stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, and Cognitive Impairment with Mild Traumatic Brain Injury (mTBI) for which there are limited or no treatment options. The Company is focused on the development of ALPHA-1062 for the treatment of mild-to-moderate Alzheimer's disease and completed an NDA filing to the FDA in September 2023. The company anticipates an FDA approval in mid-2024. The Company's ALPHA-1062 development program is primarily focused on clinical and regulatory development, Chemistry, Manufacturing and Control (CMC) development, and commercial readiness.